France· FR:60296511
EPLERENONE TEVA 50 mg, comprimé pelliculé
A eplerenone product containing éplérénone, registered in France by TEVA SANTE, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Eplerenone is registered in 17 of 19 countries.
Countries holding a registration under ATC C03DA04 (eplerenone), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Eplerenone · ATC C03DA04
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eplerenone costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.05 in France to $3.72 in Switzerland — a ×3.6 gap.
- France: $1.05 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Eplerenone · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.72
- IT Italy$1.47
- FR France$1.05
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉPLÉRÉNONE
- Manufacturer
- TEVA SANTE
- Country
- France (FR)
- ATC code
- C03DA04
- ATC class
- Eplerenone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400927973109plaquette(s) PVC PVDC aluminium de 30 comprimé(s)EUR 13.8
- cip133400927973628plaquette(s) PVC PVDC aluminium de 90 comprimé(s)EUR 38.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
230 interactions on record for eplerenone.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eplerenone · interactions on record
230 records
- 32 severe
- 97 moderate
- 3 minor
- 24 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- AprepitantA04AD12severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
74 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eplerenone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAPLERIAKrka, d.d., Novo mesto, Novo mesto
- SpainELECOR 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlmirall S.A.
- NetherlandsEplerenon Accord 50 mg filmomhulde tablettenAccord Healthcare B.V.
- SwedenEplerenon Accord 50 mg Filmdragerad tablettAccord Healthcare B.V.
- PolandEleveonZentiva, k.s.
- SwitzerlandEplerenon Sandoz
- ItalyEPLERENONE ACCORDACCORD HEALTHCARE SLU
- United StatesEplerenoneMylan Pharmaceuticals Inc.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Eplerenon +pharma, Eplerenon Actavis
- Belgium · Eplerenone Ab, Inspra
- Bulgaria · Eспиро, Аплериа
- Cyprus · Apleria, Eplerenone Accord
- Czechia · Apleria, Eplerenon Medreg
- Germany · Epleraxiro, Eplerenon 1 A Pharma
- Denmark · Eplerathen, Eplerenon Accord
- Estonia · Apleria
- Spain · Elecor, Eplerenona Alter
- Finland · Inspra
- United Kingdom (Northern Ireland) · Eplerenone, Eplerenone Accord Healthcare
- Greece · Apleria, Eleveon
- Croatia · Apleria, Diuron
- Hungary · Diupot, Eplerenon Krka
- Ireland · Eplerenone Accord Healthcare, Eplerenone Krka
- Iceland · Eplerenon Bluefish, Eplerenon Krka
- Italy · Eplerenone Accord, Eplerenone Doc Generici
- Lithuania · Apleria
- Luxembourg · Inspra
- Latvia · Enplerasa, Plecard
- Netherlands · Eplerenon Accord, Eplerenon Amarox
- Norway · Eplerenon Accord, Eplerenon Krka
- Poland · Eleveon, Enplerasa
- Portugal · Eplerenona Biofarmoz, Eplerenona Blovasc
- Romania · Apleria, Eplerenonă Arena
- Sweden · Eplerenon Accord, Eplerenon Bluefish
- Slovenia · Elreptic, Enplerasa
- Slovakia · Aldepla, Apleria
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c189f8dc-e46a-4337-b4a6-a4f5f2462254 GET /v1/drugs/c189f8dc-e46a-4337-b4a6-a4f5f2462254?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60296511",
"date_amm": "2015-11-10",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "ÉPLÉRÉNONE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about eplerenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.